PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 99 filers reported holding PTC THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $435,000 | +25.0% | 21,718 | +14.3% | 0.00% | +100.0% |
| Q2 2017 | $348,000 | +3.6% | 19,005 | -44.3% | 0.00% | 0.0% |
| Q1 2017 | $336,000 | -37.5% | 34,105 | -30.8% | 0.00% | -50.0% |
| Q4 2016 | $538,000 | +8.7% | 49,305 | +39.7% | 0.00% | 0.0% |
| Q3 2016 | $495,000 | +99.6% | 35,300 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $248,000 | +9.3% | 35,300 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $227,000 | -77.3% | 35,300 | +14.5% | 0.00% | -75.0% |
| Q4 2015 | $999,000 | +23.3% | 30,836 | +1.6% | 0.00% | 0.0% |
| Q3 2015 | $810,000 | -65.4% | 30,354 | -37.6% | 0.00% | -60.0% |
| Q2 2015 | $2,340,000 | -32.0% | 48,614 | -14.0% | 0.01% | -28.6% |
| Q1 2015 | $3,442,000 | +14.3% | 56,559 | -2.8% | 0.01% | +7.7% |
| Q4 2014 | $3,011,000 | +130.9% | 58,169 | +96.3% | 0.01% | +116.7% |
| Q3 2014 | $1,304,000 | +193.0% | 29,630 | +74.1% | 0.01% | +200.0% |
| Q2 2014 | $445,000 | +95.2% | 17,021 | +95.3% | 0.00% | +100.0% |
| Q1 2014 | $228,000 | +81.0% | 8,714 | +17.8% | 0.00% | 0.0% |
| Q4 2013 | $126,000 | +110.0% | 7,398 | +164.2% | 0.00% | – |
| Q3 2013 | $60,000 | – | 2,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 110,794 | $3,802,000 | 10.50% |
| Boxer Capital, LLC | 2,155,000 | $73,960,000 | 9.14% |
| RTW INVESTMENTS, LP | 1,922,346 | $65,975,000 | 6.14% |
| GREAT POINT PARTNERS LLC | 1,225,000 | $42,042,000 | 5.31% |
| Opaleye Management Inc. | 190,000 | $6,520,000 | 2.43% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,626,965 | $55,837,000 | 1.89% |
| SPHERA FUNDS MANAGEMENT LTD. | 345,500 | $11,858,000 | 1.34% |
| SECTORAL ASSET MANAGEMENT INC | 233,536 | $8,015,000 | 1.09% |
| Elk Creek Partners, LLC | 377,674 | $12,962,000 | 1.08% |
| Orbimed Advisors | 1,519,700 | $52,156,000 | 0.96% |